TL;DR
Get everyday helpers delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
MedPage Today published a weekly roundup of remarks from clinicians and researchers on October 18, 2026. The quotes address AI in healthcare, access to a new mRNA flu shot, and findings in several areas of medicine; the roundup reports comments rather than presenting new research itself.
MedPage Today published a weekly roundup on October 18, 2026, collecting comments from clinicians and researchers on topics ranging from AI in healthcare to pregnancy research and HIV treatment. The remarks offer a snapshot of issues discussed in medical reporting this week, but the roundup is a selection of quotations, not a report of new findings or a unified policy statement.
The roundup opens with Mishal Khan, a researcher at the UC Berkeley Labor Center, reflecting on artificial intelligence in healthcare: “Tech is not good or bad, but neither is it neutral.” Her comment frames AI as a technology whose effects depend on how it is designed and used, rather than as inherently beneficial or harmful. The source does not provide further detail about the specific AI system or study behind the remark.
Several other quotes address access and interpretation of medical evidence. Amesh Adalja of the Johns Hopkins Center for Health Security said people seeking the new mRNA flu shot, mFlusiva, would need to use a website or call around. The roundup also includes Krista Huybrechts of Brigham and Women’s Hospital, who described findings on benzodiazepine use early in pregnancy as reassuring while cautioning that the drugs are not risk-free.
Other comments cover pulmonary vascular resistance after heart transplantation, possible cancer risk among people with sickle cell disease, advanced HIV disease, and screening for pediatric obesity. The speakers urged care in interpreting these issues: one said pulmonary vascular resistance should not be read in isolation, while another said the evidence on cancer risk had not yet met the burden of proof. The source offers brief comments rather than full descriptions of the underlying studies.
What the Quotes Signal for Care
The collection matters as a concise guide to current medical discussions, especially where research findings can be overstated or separated from the conditions in which they apply. The comments on pregnancy medication and cancer risk, for example, distinguish between reassuring or emerging evidence and a definitive conclusion. That distinction is important for readers encountering headlines about health studies.
The remarks also point to practical concerns beyond research results. Adalja’s comment raises an access question about obtaining mFlusiva, while Khan’s observation directs attention to the choices and systems shaping AI’s effects in healthcare. These are comments from individual experts, not evidence that a particular access problem or technology outcome has been independently established in this roundup.
As an affiliate, we earn on qualifying purchases.
A Weekly Medical Quote Roundup
MedPage Today’s “What We Heard This Week” feature gathers notable statements reported by its journalists. The October 18 edition includes eight quotes from professionals associated with universities, hospitals, research organizations and medical societies. Its format is brief: each statement is paired with the speaker’s name, affiliation and a short description of the topic.
That format provides useful pointers to subjects covered in medical reporting, but it does not replace the studies or interviews behind them. The roundup does not supply study methods, sample sizes, numerical results or complete explanations of the speakers’ reasoning. Readers who want to evaluate any scientific claim need the underlying research and fuller reporting.
““Tech is not good or bad, but neither is it neutral.””
— Mishal Khan, PhD, UC Berkeley Labor Center
What the Brief Excerpts Leave Open
The roundup does not provide enough detail to assess the underlying evidence or settle the medical questions raised. For instance, it gives no study design or numerical results for the pregnancy, transplant, sickle cell, HIV or obesity research. It also does not explain what website or other channels are available for mFlusiva, or identify the specific AI application behind Khan’s comment.
The quotes should not be treated as the full views of the speakers or as clinical guidance. Their conclusions and qualifications may depend on evidence and context that are not included in the short excerpts. The source does not report new recommendations, regulatory decisions or changes in clinical practice.
Follow the Studies Behind the Quotes
The next step for readers interested in any of these topics is to consult the original studies and fuller MedPage Today coverage cited in connection with the remarks. Those materials can clarify the methods, results and limits of each finding. The roundup itself announces no further event, publication date or policy action, so any later developments remain to be reported separately.
Key Questions
What did MedPage Today publish on October 18, 2026?
It published a weekly collection of quotes from reporters’ coverage of healthcare topics, including AI, an mRNA flu shot and several medical studies.
Does the roundup report new medical research?
No. It presents comments about research and healthcare issues. It does not include full study results or announce new findings of its own.
What did the AI comment say?
Mishal Khan said, “Tech is not good or bad, but neither is it neutral,” while discussing AI in healthcare. The roundup does not specify a particular tool or study.
What did the roundup say about benzodiazepines in early pregnancy?
Krista Huybrechts described study findings on congenital malformations as reassuring, while stressing that benzodiazepines are not risk-free. The excerpt does not provide the study’s methods or results in detail.
Source: rss
Halloween Picks
halloween
As an affiliate, we earn on qualifying purchases.
